Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (845)
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
3,605
Price
$114.70
Total Value
$413.48K
Shares Held After
105,750
% of Holdings
3.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
1,000
Price
$112.86
Total Value
$112.86K
Shares Held After
109,355
% of Holdings
0.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
2,300
Price
$111.80
Total Value
$257.14K
Shares Held After
110,355
% of Holdings
2.0%
Septerna, Inc. (SEPN)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
746,500
Price
$42.50
Total Value
$31.73M
Shares Held After
725,443
% of Holdings
50.7%
Septerna, Inc. (SEPN)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
746,500
Price
$42.50
Total Value
$31.73M
Shares Held After
4,777,415
% of Holdings
13.5%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
2,419
Price
$43.80
Total Value
$105.95K
Shares Held After
17,697
% of Holdings
12.0%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
99
Price
$44.50
Total Value
$4.41K
Shares Held After
20,116
% of Holdings
0.5%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
59
Price
$44.41
Total Value
$2.62K
Shares Held After
20,215
% of Holdings
0.3%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
2,439
Price
$43.81
Total Value
$106.85K
Shares Held After
20,274
% of Holdings
10.7%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
2,475
Price
$43.70
Total Value
$108.15K
Shares Held After
31,826
% of Holdings
7.2%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
150
Price
$44.44
Total Value
$6.67K
Shares Held After
34,301
% of Holdings
0.4%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
304
Price
$44.50
Total Value
$13.53K
Shares Held After
34,451
% of Holdings
0.9%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
2,171
Price
$43.79
Total Value
$95.08K
Shares Held After
34,755
% of Holdings
5.9%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
390
Price
$44.46
Total Value
$17.34K
Shares Held After
31,466
% of Holdings
1.2%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
2,273
Price
$43.68
Total Value
$99.28K
Shares Held After
31,856
% of Holdings
6.7%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
3,238
Price
$43.68
Total Value
$141.43K
Shares Held After
34,129
% of Holdings
8.7%
Edgewise Therapeutics, Inc. (EWTX)
KOCH KEVIN — Director
Shares
913
Price
$44.33
Total Value
$40.47K
Shares Held After
52,488
% of Holdings
1.7%
Edgewise Therapeutics, Inc. (EWTX)
KOCH KEVIN — Director
Shares
8,276
Price
$43.66
Total Value
$361.32K
Shares Held After
53,401
% of Holdings
13.4%
Edgewise Therapeutics, Inc. (EWTX)
KOCH KEVIN — Director
Shares
8,782
Price
$43.64
Total Value
$383.25K
Shares Held After
61,677
% of Holdings
12.5%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
800
Price
$44.52
Total Value
$35.61K
Shares Held After
11,544
% of Holdings
6.5%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
104
Price
$44.43
Total Value
$4.62K
Shares Held After
12,344
% of Holdings
0.8%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,779
Price
$43.71
Total Value
$121.46K
Shares Held After
12,448
% of Holdings
18.3%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,839
Price
$43.78
Total Value
$124.30K
Shares Held After
15,227
% of Holdings
15.7%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
7,138
Price
$292.81
Total Value
$2.09M
Shares Held After
3,981
% of Holdings
64.2%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
31,641
Price
$292.06
Total Value
$9.24M
Shares Held After
27,696
% of Holdings
53.3%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
10,803
Price
$120.04
Total Value
$1.30M
Shares Held After
194,001
% of Holdings
5.3%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
46,387
Price
$10.37
Total Value
$481.03K
Shares Held After
1,319,784
% of Holdings
3.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
223
Price
$180.57
Total Value
$40.27K
Shares Held After
93,433
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
144
Price
$180.00
Total Value
$25.92K
Shares Held After
93,656
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
223
Price
$180.57
Total Value
$40.27K
Shares Held After
170,569
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
142
Price
$180.00
Total Value
$25.56K
Shares Held After
170,792
% of Holdings
0.1%
Wave Life Sciences, Inc. (WVE)
Rawcliffe Adrian — Director
Shares
12,700
Price
$5.29
Total Value
$67.18K
Shares Held After
0
% of Holdings
100.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
6,700
Price
$26.08
Total Value
$174.77K
Shares Held After
119,289
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
41
Price
$520.96
Total Value
$21.36K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
679
Price
$520.38
Total Value
$353.34K
Shares Held After
324,484
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$519.49
Total Value
$602.61K
Shares Held After
325,163
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$518.16
Total Value
$165.81K
Shares Held After
326,323
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,249
Price
$517.21
Total Value
$646.00K
Shares Held After
326,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
940
Price
$516.16
Total Value
$485.19K
Shares Held After
327,892
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
893
Price
$514.87
Total Value
$459.78K
Shares Held After
328,832
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
558
Price
$514.18
Total Value
$286.91K
Shares Held After
329,725
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$513.02
Total Value
$618.70K
Shares Held After
330,283
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
542
Price
$511.75
Total Value
$277.37K
Shares Held After
331,489
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,152
Price
$511.12
Total Value
$588.81K
Shares Held After
332,031
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$509.61
Total Value
$142.69K
Shares Held After
333,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$508.86
Total Value
$223.90K
Shares Held After
333,463
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$507.08
Total Value
$20.28K
Shares Held After
333,903
% of Holdings
0.0%
X4 Pharmaceuticals, Inc (XFOR)
Volpone John — President
Shares
24,576
Price
$4.44
Total Value
$109.23K
Shares Held After
265,305
% of Holdings
8.5%
Zai Lab Ltd (ZLAB)
Lis William — Director
Shares
8,506
Price
$25.00
Total Value
$212.65K
Shares Held After
41,931
% of Holdings
16.9%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
47,436
Price
$4.44
Total Value
$210.83K
Shares Held After
328,651
% of Holdings
12.6%
Showing 51–100 of 845 transactions (page 2 of 17)